Hot Features
Premium
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Zeitraum:
Zeichenmodus:
| Volumen | 0 |
|
|||||
| News | - |
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| Reviva Pharmaceuticals Holdings Inc | RVPHW | NASDAQ | Equity Warrant |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| 0,00 | 0,00% | 0,003 | 02:00:00 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 0,003 |
| Trades | Volumen | Durchsch. Volumen |
|---|---|---|
| 0 | 0 | - |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| - | 0 | 0,003 | USD |
Finanzwerte RVPHW
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 345,18k | - | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Reviva Pharmaceuticals
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 19.12.2025 | 22:18 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 05.12.2025 | 22:19 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
| 13.11.2025 | 22:19 | Edgar (US Regulatory) | Form 8-K - Current report |
| 13.11.2025 | 22:11 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 04.11.2025 | 22:21 | Edgar (US Regulatory) | Form ARS - Annual Report to Security Holders |
| 04.11.2025 | 22:20 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
| 04.11.2025 | 22:16 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
| 24.10.2025 | 22:30 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements |
| 17.10.2025 | 22:31 | Edgar (US Regulatory) | Form 8-K - Current report |
| 26.9.2025 | 23:10 | Edgar (US Regulatory) | Form 8-K - Current report |
| 19.9.2025 | 23:27 | Edgar (US Regulatory) | Form 8-K - Current report |
| 19.9.2025 | 23:26 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
Forum Reviva Pharmaceuticals
Keine Diskussionen Gefunden.Neuen Thread Erstellen
RVPHW Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 1 Monat | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 3 Monate | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 6 Monate | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 1 Jahr | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 3 Jahre | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 5 Jahre | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
NASDAQ:RVPHW -
What is the current Reviva Pharmaceuticals Holdings Inc share price?
The current share price of Reviva Pharmaceuticals Holdings Inc is US$ 0,003
What is the 1 year trading range for Reviva Pharmaceuticals Holdings Inc share price?
Reviva Pharmaceuticals Holdings Inc has traded in the range of US$ 0,00 to US$ 0,00 during the past year
